Literature DB >> 20853129

Transformation of amyloid β(1-40) oligomers into fibrils is characterized by a major change in secondary structure.

Rabia Sarroukh1, Emilie Cerf, Sylvie Derclaye, Yves F Dufrêne, Erik Goormaghtigh, Jean-Marie Ruysschaert, Vincent Raussens.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder occurring in the elderly. It is widely accepted that the amyloid beta peptide (Aβ) aggregation and especially the oligomeric states rather than fibrils are involved in AD onset. We used infrared spectroscopy to provide structural information on the entire aggregation pathway of Aβ(1-40), starting from monomeric Aβ to the end of the process, fibrils. Our structural study suggests that conversion of oligomers into fibrils results from a transition from antiparallel to parallel β-sheet. These structural changes are described in terms of H-bonding rupture/formation, β-strands reorientation and β-sheet elongation. As antiparallel β-sheet structure is also observed for other amyloidogenic proteins forming oligomers, reorganization of the β-sheet implicating a reorientation of β-strands could be a generic mechanism determining the kinetics of protein misfolding. Elucidation of the process driving aggregation, including structural transitions, could be essential in a search for therapies inhibiting aggregation or disrupting aggregates.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20853129     DOI: 10.1007/s00018-010-0529-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  56 in total

Review 1.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

2.  Fusogenic Alzheimer's peptide fragment Abeta (29-42) in interaction with lipid bilayers: secondary structure, dynamics, and specific interaction with phosphatidyl ethanolamine polar heads as revealed by solid-state NMR.

Authors:  Stéphanie Ravault; Olivier Soubias; Olivier Saurel; Annick Thomas; Robert Brasseur; Alain Milon
Journal:  Protein Sci       Date:  2005-05       Impact factor: 6.725

3.  High-resolution atomic force microscopy of soluble Abeta42 oligomers.

Authors:  Iris A Mastrangelo; Mahiuddin Ahmed; Takeshi Sato; Wei Liu; Chengpu Wang; Paul Hough; Steven O Smith
Journal:  J Mol Biol       Date:  2006-01-30       Impact factor: 5.469

4.  Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

Authors:  Hai-Wei Wang; Joseph F Pasternak; Helen Kuo; Helen Ristic; Mary P Lambert; Brett Chromy; Kirsten L Viola; William L Klein; W Blaine Stine; Grant A Krafft; Barbara L Trommer
Journal:  Brain Res       Date:  2002-01-11       Impact factor: 3.252

5.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  Neurotoxic protein oligomers--what you see is not always what you get.

Authors:  Gal Bitan; Erica A Fradinger; Sean M Spring; David B Teplow
Journal:  Amyloid       Date:  2005-06       Impact factor: 7.141

7.  The correlation between neurotoxicity, aggregative ability and secondary structure studied by sequence truncated Abeta peptides.

Authors:  M Q Liao; Y J Tzeng; Lea Y X Chang; H B Huang; T H Lin; C L Chyan; Y C Chen
Journal:  FEBS Lett       Date:  2007-02-20       Impact factor: 4.124

8.  Supramolecular structure in full-length Alzheimer's beta-amyloid fibrils: evidence for a parallel beta-sheet organization from solid-state nuclear magnetic resonance.

Authors:  John J Balbach; Aneta T Petkova; Nathan A Oyler; Oleg N Antzutkin; David J Gordon; Stephen C Meredith; Robert Tycko
Journal:  Biophys J       Date:  2002-08       Impact factor: 4.033

Review 9.  A beta oligomers - a decade of discovery.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  J Neurochem       Date:  2007-02-05       Impact factor: 5.372

10.  Computational selection of inhibitors of Abeta aggregation and neuronal toxicity.

Authors:  Deliang Chen; Zane S Martin; Claudio Soto; Catherine H Schein
Journal:  Bioorg Med Chem       Date:  2009-05-27       Impact factor: 3.641

View more
  41 in total

Review 1.  Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.

Authors:  Jessica Nasica-Labouze; Phuong H Nguyen; Fabio Sterpone; Olivia Berthoumieu; Nicolae-Viorel Buchete; Sébastien Coté; Alfonso De Simone; Andrew J Doig; Peter Faller; Angel Garcia; Alessandro Laio; Mai Suan Li; Simone Melchionna; Normand Mousseau; Yuguang Mu; Anant Paravastu; Samuela Pasquali; David J Rosenman; Birgit Strodel; Bogdan Tarus; John H Viles; Tong Zhang; Chunyu Wang; Philippe Derreumaux
Journal:  Chem Rev       Date:  2015-03-19       Impact factor: 60.622

2.  Probing ion channel activity of human islet amyloid polypeptide (amylin).

Authors:  Jun Zhao; Yin Luo; Hyunbum Jang; Xiang Yu; Guanghong Wei; Ruth Nussinov; Jie Zheng
Journal:  Biochim Biophys Acta       Date:  2012-08-23

3.  Structural insights into Aβ42 oligomers using site-directed spin labeling.

Authors:  Lei Gu; Cong Liu; Zhefeng Guo
Journal:  J Biol Chem       Date:  2013-05-16       Impact factor: 5.157

4.  Mechanisms of transthyretin inhibition of β-amyloid aggregation in vitro.

Authors:  Xinyi Li; Xin Zhang; Ali Reza A Ladiwala; Deguo Du; Jay K Yadav; Peter M Tessier; Peter E Wright; Jeffery W Kelly; Joel N Buxbaum
Journal:  J Neurosci       Date:  2013-12-11       Impact factor: 6.167

5.  Spectroscopic Signature for Stable β-Amyloid Fibrils versus β-Sheet-Rich Oligomers.

Authors:  Justin P Lomont; Kacie L Rich; Michał Maj; Jia-Jung Ho; Joshua S Ostrander; Martin T Zanni
Journal:  J Phys Chem B       Date:  2017-12-27       Impact factor: 2.991

6.  Characterization of Protein Structural Changes in Living Cells Using Time-Lapsed FTIR Imaging.

Authors:  Paul Gelfand; Randy J Smith; Eli Stavitski; David R Borchelt; Lisa M Miller
Journal:  Anal Chem       Date:  2015-05-28       Impact factor: 6.986

Review 7.  Insight into amyloid structure using chemical probes.

Authors:  Ashley A Reinke; Jason E Gestwicki
Journal:  Chem Biol Drug Des       Date:  2011-04-26       Impact factor: 2.817

Review 8.  Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease.

Authors:  Samuel A Kotler; Patrick Walsh; Jeffrey R Brender; Ayyalusamy Ramamoorthy
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

Review 9.  Impact of apolipoprotein E on Alzheimer's disease.

Authors:  Paul S Hauser; Robert O Ryan
Journal:  Curr Alzheimer Res       Date:  2013-10       Impact factor: 3.498

10.  A Free Energy Barrier Caused by the Refolding of an Oligomeric Intermediate Controls the Lag Time of Amyloid Formation by hIAPP.

Authors:  Arnaldo L Serrano; Justin P Lomont; Ling-Hsien Tu; Daniel P Raleigh; Martin T Zanni
Journal:  J Am Chem Soc       Date:  2017-11-07       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.